These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 21463871)
1. Increased plasma levels of lipocalin 2 in mild cognitive impairment. Choi J; Lee HW; Suk K J Neurol Sci; 2011 Jun; 305(1-2):28-33. PubMed ID: 21463871 [TBL] [Abstract][Full Text] [Related]
2. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease. Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636 [TBL] [Abstract][Full Text] [Related]
3. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945 [TBL] [Abstract][Full Text] [Related]
5. Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis. Chun BY; Kim JH; Nam Y; Huh MI; Han S; Suk K Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3691-8. PubMed ID: 26047170 [TBL] [Abstract][Full Text] [Related]
6. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084 [TBL] [Abstract][Full Text] [Related]
7. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. Naudé PJ; Nyakas C; Eiden LE; Ait-Ali D; van der Heide R; Engelborghs S; Luiten PG; De Deyn PP; den Boer JA; Eisel UL FASEB J; 2012 Jul; 26(7):2811-23. PubMed ID: 22441986 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix. Wu CH; Ko JL; Chen SC; Lin YW; Han CP; Yang TY; Chien MH; Wang PH Gynecol Oncol; 2014 Feb; 132(2):474-82. PubMed ID: 24316309 [TBL] [Abstract][Full Text] [Related]
9. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377 [TBL] [Abstract][Full Text] [Related]
10. Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease. Oberoi R; Bogalle EP; Matthes LA; Schuett H; Koch AK; Grote K; Schieffer B; Schuett J; Luchtefeld M PLoS One; 2015; 10(9):e0137924. PubMed ID: 26367277 [TBL] [Abstract][Full Text] [Related]
11. Plasma lipocalin-2 levels in pregnant women with pre-eclampsia, and their relation with severity of disease. Cemgil Arikan D; Ozkaya M; Adali E; Kilinc M; Coskun A; Ozer A; Bilge F J Matern Fetal Neonatal Med; 2011 Feb; 24(2):291-6. PubMed ID: 20504246 [TBL] [Abstract][Full Text] [Related]
12. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615 [TBL] [Abstract][Full Text] [Related]
13. Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer. Lin CW; Tseng SW; Yang SF; Ko CP; Lin CH; Wei LH; Chien MH; Hsieh YS Oral Dis; 2012 Nov; 18(8):734-40. PubMed ID: 22533572 [TBL] [Abstract][Full Text] [Related]
14. The relationship between subclinical cardiovascular disease and lipocalin-2 levels in women with PCOS. Gencer M; Gazi E; Hacıvelioğlu S; Binnetoğlu E; Barutçu A; Türkön H; Temiz A; Altun B; Vural A; Cevizci S; Kumcular T; Coşar E Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():99-103. PubMed ID: 25145761 [TBL] [Abstract][Full Text] [Related]
15. Serum lipocalin-2 levels are increased in patients with psoriasis. Kamata M; Tada Y; Tatsuta A; Kawashima T; Shibata S; Mitsui H; Asano Y; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S Clin Exp Dermatol; 2012 Apr; 37(3):296-9. PubMed ID: 22300286 [TBL] [Abstract][Full Text] [Related]
16. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease. Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707 [TBL] [Abstract][Full Text] [Related]
17. A Novel Plasma Based Biomarker of Alzheimer's Disease. Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710 [TBL] [Abstract][Full Text] [Related]
18. Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence. Li X; Wang X; Guo L; Wu K; Wang L; Rao L; Liu X; Kang C; Jiang B; Li Q; Li H; He F; Lu C Ageing Res Rev; 2023 Aug; 89():101984. PubMed ID: 37330019 [TBL] [Abstract][Full Text] [Related]
19. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease. Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013 [TBL] [Abstract][Full Text] [Related]
20. The role of lipocalin-2 in liver regeneration. Kienzl-Wagner K; Moschen AR; Geiger S; Bichler A; Aigner F; Brandacher G; Pratschke J; Tilg H Liver Int; 2015 Apr; 35(4):1195-202. PubMed ID: 25040147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]